NMIN

about us

The NanoMedicines Innovation Network (NMIN) is advancing “smart” medicines to defeat disease by delivering small molecule drugs to disease sites and accelerating gene therapy.

NMIN brings 60 Principal Investigators from 17 institutions across Canada together with 15 companies and 8 not-for-profit research and granting institutions to establish a network to expand and improve Canada’s position as a leader in nanomedicines R&D.

NMIN is funded by the Government of Canada through the Networks of Centres of Excellence (NCE) Program.

Latest news...

UBC attracts over $40M to host Networks of Centres of Excellence in nanomedicines Apr 16, 2019 …
NMIN

Our focus

Develop nanomedicines

that enhance the therapeutic properties of small molecule drugs, and enable gene therapies.

Develop new diagnostics

that enable more precise disease detection and treatment, based on nanotechnology.

Train scientists

in the technology and business of nanomedicines, guided by market needs for HQP with skills required by the R&D community.

Translate nanomedicine

products and technologies, by implementing a cohesive IP and commercialization strategy.

NMIN

Scientific Leadership

Pieter Cullis

Scientific Director

Christine Allen

Associate Scientific Director

Gilbert Walker

Associate Scientific Director

NMIN

Contact

NMIN NCE Inc.

2350 Health Sciences Mall, Room 5451 | University of British Columbia | Vancouver, BC V6T 1Z3 Canada
info@nanomedicines.ca

NMIN NCE Inc.

2350 Health Sciences Mall, Room 5451 | University of British Columbia | Vancouver, BC V6T 1Z3 Canada
info@nanomedicines.ca